CASP3 and leukemia: Changes in caspase-8 and caspase-3 activity in the two leukemia cell lines were markedly greater than those in the LO2 and T cells (Figure 5C), mirroring the different fate of the four cell lines after treatment with sTRAIL:FeSOD.